EF-Tu is dynamically regulated during the chlamydial developmental cycle:
Replicative Phase (Reticulate Bodies, RBs): EF-Tu is highly abundant in RBs, supporting rapid protein synthesis for bacterial replication .
Infectious Phase (Elementary Bodies, EBs): Lower EF-Tu levels correlate with reduced metabolic activity in EBs .
Persistent Forms (Aberrant RBs, ARBs): Under interferon-γ stress, EF-Tu expression persists, enabling survival despite host immune pressure .
| Growth Form | EF-Tu Abundance (% Total Protein) | Key Function |
|---|---|---|
| Reticulate Body | 2.1% | Protein synthesis, replication |
| Elementary Body | 0.8% | Structural maintenance |
| Aberrant RB | 1.9% | Stress adaptation |
The tuf gene serves as a reliable reference in qPCR for quantifying chlamydial genomic DNA (gDNA) due to its single-copy nature and stable expression .
The tuf ribosome-binding site (RBS) enhances heterologous gene expression in C. trachomatis. For example:
A GFP reporter plasmid using the tuf RBS achieved detectable fluorescence in C. trachomatis inclusions by 16 hours post-infection .
Dual-reporter systems (e.g., GFP/mCherry) leverage tuf RBS for normalization in promoter activity studies .
Antibiotic Resistance: EF-Tu’s interaction with ribosomes may influence responses to antibiotics like moxifloxacin, as tuf expression stability affects bacterial recovery under drug pressure .
Diagnostic Potential: EF-Tu’s immunogenicity makes it a candidate for serodiagnostic assays targeting chlamydial infections .
KEGG: ctb:CTL0574
Elongation factor Tu (tuf) is a highly conserved bacterial protein essential for protein synthesis in C. trachomatis. It functions during the elongation phase of translation by delivering aminoacyl-tRNAs to the ribosome. The protein forms a ternary complex with GTP and aminoacyl-tRNA that interacts with the ribosome during translation. Following correct codon-anticodon pairing, GTP is hydrolyzed to GDP, and EF-Tu is released from the ribosome.
The tuf protein in C. trachomatis consists of 394 amino acids, as indicated in available product information . The amino acid sequence includes GTP-binding domains and regions responsible for interacting with aminoacyl-tRNAs and the ribosome. Given C. trachomatis' nature as an obligate intracellular pathogen with a unique developmental cycle, the tuf protein is crucial for understanding the organism's biology and pathogenesis.
Recombinant C. trachomatis tuf protein is typically expressed in E. coli expression systems, which provide high yield and relatively straightforward purification protocols. Commercial preparations predominantly use E. coli as the expression host .
The standard expression and purification process includes:
Cloning the full-length tuf gene (encoding all 394 amino acids) into an appropriate expression vector
Transforming the construct into a suitable E. coli strain optimized for protein expression
Inducing protein expression under controlled conditions
Cell lysis followed by multi-step purification
Purification typically employs:
Affinity chromatography using tags such as His-tag or SUMO-tag systems
Size exclusion chromatography for further purification
Final preparation as either lyophilized powder or in stabilizing buffer
This process yields highly pure protein suitable for various research applications while maintaining the structural and functional integrity of the native tuf protein.
The tuf protein from C. trachomatis serovar L2 is a GTP-binding protein with several conserved structural domains. Based on the amino acid sequence available , key structural features include:
Three main domains:
Domain I: N-terminal domain containing GTP/GDP binding sites and catalytic center
Domain II: Middle domain involved in aminoacyl-tRNA interactions
Domain III: C-terminal domain contributing to protein stability and function
Key functional motifs include:
G1 motif (GXXXXGK) for phosphate binding
G2 motif (DXXG) involved in Mg²⁺ coordination
G3 motif (NKXD) for base specificity
G4 motif (NXXA) for guanine recognition
The full sequence of 394 amino acids forms a protein with a molecular weight of approximately 43-45 kDa. The protein undergoes significant conformational changes during its functional cycle, transitioning between GTP-bound (active) and GDP-bound (inactive) states.
Studying tuf gene regulation in C. trachomatis requires specialized approaches due to the organism's obligate intracellular lifestyle. Several methodologies have proven effective:
Promoter analysis: The tuf gene in C. trachomatis is regulated by σ66-specific promoters, which often contain -35 (TTGACA) and -10 (TATAAT) consensus elements similar to E. coli σ70 promoters with an optimal ~17-bp spacer . Researchers can analyze these promoter elements using:
Transcriptional analysis:
Developmental regulation studies:
Understanding tuf regulation provides important insights into how C. trachomatis modulates its translational machinery during different stages of its developmental cycle.
Due to the obligate intracellular nature of C. trachomatis, specialized experimental approaches are required to study tuf function:
In vitro biochemical assays:
GTP binding and hydrolysis assays with purified recombinant tuf
Aminoacyl-tRNA binding studies
Ribosome interaction analyses
Cell culture-based approaches:
Hybrid systems:
Genetic approaches:
Transformation with fluorescent-tagged tuf constructs
Site-directed mutagenesis to investigate structure-function relationships
Comparative genomics:
Analysis of tuf sequence conservation across Chlamydia serovars
Identification of unique structural features compared to tuf from other bacteria
These methodologies allow researchers to overcome the challenges of working with this difficult-to-cultivate pathogen while gaining valuable insights into tuf function.
The expression of tuf during the C. trachomatis developmental cycle follows a pattern that reflects the metabolic needs of the organism:
Early phase (0-12 hours post-infection):
Middle phase (12-24 hours):
Late phase (24-48+ hours):
RBs begin converting back to EBs
Gradual decrease in tuf expression as metabolic activity declines
Differential regulation as the bacterium prepares for release and new infection
The timing of peak tuf expression may be manipulated experimentally by factors that affect the developmental cycle, such as cytokines like TNF-α, which has been shown to inhibit C. trachomatis growth even when added up to 12 hours after infection .
Recombinant C. trachomatis tuf protein serves as a valuable component in quality control materials for diagnostic assays, particularly nucleic acid amplification tests (NAATs):
Standard material preparation:
Recombinant tuf protein provides consistent, reproducible control material
Can be used to establish standard curves for quantitative assays
Serves as positive control in immunoassays
Quality control material applications:
Advantages as quality control material:
Implementation approaches:
Integration into diagnostic workflows as positive controls
Use in proficiency testing programs
Application in assay development and optimization
The use of recombinant proteins like tuf represents a significant improvement over traditional quality control materials derived from cultured organisms, offering greater reproducibility and stability .
The relationship between tuf and antibiotic susceptibility in C. trachomatis involves several interconnected mechanisms:
Direct antibiotic interactions:
In some bacteria, EF-Tu is a target for antibiotics like kirromycin
Structural variations in C. trachomatis tuf may influence binding of such antibiotics
Point mutations could potentially confer resistance
Translational effects on resistance determinants:
As a key component of protein synthesis, tuf indirectly affects expression of all bacterial proteins
Modulation of tuf activity can influence production of proteins involved in antibiotic resistance
Translational efficiency impacts the bacterium's ability to respond to antibiotic stress
Developmental stage considerations:
Differential expression of tuf across developmental stages correlates with varying antibiotic susceptibilities
Elementary bodies (EBs) with reduced tuf activity are generally more resistant to antibiotics targeting protein synthesis
Reticulate bodies (RBs) with high tuf activity are typically more susceptible
Persistent infection mechanisms:
Research examining these relationships typically employs experimental approaches such as comparative analysis of antibiotic-resistant isolates and assessment of tuf expression under antibiotic pressure.
Differentiating the functions of tuf in C. trachomatis from those in other bacteria requires a multifaceted approach:
Comparative sequence analysis:
Alignment of tuf sequences across bacterial species
Identification of unique residues in C. trachomatis tuf
Evolutionary analysis to identify selectively constrained regions
Structural biology approaches:
Crystallography or cryo-EM of C. trachomatis tuf
Comparison with structures from model organisms
Identification of structural differences that may relate to functional variations
Heterologous expression studies:
Complementation experiments in E. coli tuf mutants
Assessment of functional interchangeability
Identification of species-specific interactions
Promoter regulation comparison:
Protein interaction networks:
Identification of C. trachomatis-specific tuf-interacting partners
Comparison with interaction networks in model organisms
Discovery of unique moonlighting functions
This comparative approach reveals how tuf function has been adapted to the unique intracellular lifestyle and developmental cycle of C. trachomatis, providing insights into bacterial evolution and specialization.
While primarily known for its role in translation, tuf may contribute to host-pathogen interactions during C. trachomatis infection through several mechanisms:
Potential moonlighting functions:
In other bacteria, tuf has been shown to function beyond translation
Possible roles in adhesion to host cells or extracellular matrix
Potential interactions with host cytoskeletal components
Immune recognition:
As a highly conserved bacterial protein, tuf may be recognized by host pattern recognition receptors
May contribute to innate immune activation
Could serve as a target for adaptive immune responses
Modulation by host factors:
Developmental regulation in response to host environment:
tuf expression changes during the developmental cycle in response to host conditions
May participate in sensing environmental cues within the inclusion
Could contribute to decisions regarding persistence or continued development
Experimental approaches to investigate these roles:
Co-immunoprecipitation studies to identify host interaction partners
Localization studies during different infection stages
Assessment of immune responses to recombinant tuf protein
Understanding these non-canonical roles of tuf provides deeper insights into the complex relationship between C. trachomatis and its host cells.
Proper storage and handling of recombinant C. trachomatis tuf protein is critical for maintaining its structural integrity and functional properties:
| Form | Storage Temperature | Shelf Life | Recommendations |
|---|---|---|---|
| Lyophilized | -20°C to -80°C | 12 months | Keep sealed, protect from moisture |
| Reconstituted | -20°C to -80°C | 6 months | Add 5-50% glycerol, store in aliquots |
| Working solution | 4°C | Up to 1 week | Avoid repeated freeze-thaw cycles |
Reconstitution protocol:
Briefly centrifuge the vial before opening to collect material at the bottom
Reconstitute in deionized sterile water to 0.1-1.0 mg/mL
Add glycerol to a final concentration of 50% for optimal stability
Prepare small working aliquots to avoid repeated freeze-thaw cycles
Additional considerations:
Avoid exposing the protein to extreme pH conditions
Minimize exposure to proteases
For long-term experiments, verify protein activity periodically
Consider the addition of reducing agents if the protein contains cysteines
Following these guidelines ensures maximum stability and consistency in experimental results when working with recombinant tuf protein .
Several promising research directions involving C. trachomatis tuf offer potential for significant advances:
Structural biology:
High-resolution structures of C. trachomatis tuf in different nucleotide-bound states
Comparative analysis with tuf from other bacteria
Structure-based drug design targeting unique features of chlamydial tuf
Systems biology:
Integration of tuf function into comprehensive models of C. trachomatis development
Network analysis of tuf interactions throughout the developmental cycle
Computational modeling of translational efficiency under different conditions
Diagnostic applications:
Therapeutic targets:
Vaccine development:
Assessment of tuf-based subunit vaccines
Evaluation of immune responses to conserved vs. variable tuf epitopes
Investigation of tuf as a carrier protein for other antigens
Evolutionary studies:
Analysis of tuf conservation across Chlamydia species and strains
Investigation of tuf adaptation to the intracellular lifestyle
Identification of selective pressures on tuf during host switching events